Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (54)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Garcea, R.
Right arrow Articles by Feo, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garcea, R.
Right arrow Articles by Feo, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1988 Oxford University Press

research-article

Reversal by ribo- and deoxyribonucleosides of dehydroepiandrosterone-induced inhibition of enzyme altered foci in the liver of rats subjected to the initiation-selection process of experimental carcinogenesis

Renato Garcea, Lucia Danio, Serenella Frassetto, Patrizia Cozzolino, Maria E. Ruggiu, Maria G. Vannini, Rosa Pascale, Luciano Lenzerini, Maria M. Simile, Marco Puddu and Francesco Feo 1

Istituto di Patologia generale dell' Università di Sassan Via P. Manzella 4, 07100 Sassari, Italy

1To whom correspondence should be addressed

The effect of dehydroepiandrosterone (DHEA) on the activity of NADPH-producing enzymes and the development of enzyme-altered foci has been investigated in the liver of female Wistar rats subjected to an initiating treatment (a necrogenic dose of diethylnitrosaimine) followed, 15 days later, by a selection treatment [a 15-day feeding of a diet containing 0.03% 2-acetylamlnofluorene (2-AAF), with a partial hepatectomy at the midpoint of this feeding]. At the end of the selection treatment all rat groups received, for 15 days, a basal diet containing, when indicated, 0.05% phenobarbital (PB) and/or 0.6% DHEA. The effect of DHEA on the activity of NADPH producing enzymes was also studied in normal rats fed, for 15 days, a diet containing 0.6% DHEA and in their pair-fed controls. DHEA caused a 43–58% inhibition of glucose-6-phosphate dehydrogenase (G6PD) and, respectively, 338–420% and 21–24% increases in malic enzyme (ME) and isocitric dehydrogenase activities in all rat groups. This was coupled with a great fall in the production of ribulose-5-phosphate, while no change in NADP+/NADPH ratio occurred. Hepatocytes, isolated from DHEA-treated rats, exhibited a very low activity of hexose monophosphate shunt (HMS), which was not stimulated by methylene blue, an exogenous oxidizing agent that markedly stimulated HMS activity in control hepatocytes. DHEA caused a great fall in the percentage of liver occupied by {gamma}-glutamyltranspeptidase (GGT)-positive foci, in the rats subjected to the initiation - selection treatments. PB enhanced the development of these foci, an effect which was completely overcome by DHEA. In addition, focal cells no longer expressed a G6PD activity higher than that of surrounding liver in DHEA-treated rats, but exhibited a high histochemical reaction for ME. DHEA also caused a great fall in labelling index of GGT-positive foci. Starting at the end of 2-AAF feeding, a mixture of ribonucleosides (RNs) of adenine, cytosine, guanine and uracil and of deoxyribonucleosides (DRNs) of adenine, cytosine, guanine and thymine were injected i.p. every 8 h for 12 days to the rats subjected to the initiation - selection treatments plus PB. Rats were killed 3 days after the end of RN and DRN treatments. These treatments completely overcome the DHEA effect on the development of GGT-positive foci and DNA synthesis by the focal cells, without affecting G6PD activity of both whole liver and putative preneoplastic foci. Experiments with labeled nucleosides revealed that RNs and DRNs produced derivatives that were incorporated into liver DNA. These data indicate that liver of DHEA-treated rats produce enough NADPH for reduction of RNs to DRNs and growth. The antipromoting effect of DHEA could depend on a relative deficiency of nudeosides for DNA synthesis, caused by a great fall in pentose phosphate production.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
S. L. Ripp, K. C. Falkner, M. L. Pendleton, V. Tamasi, and R. A. Prough
Regulation of CYP2C11 by Dehydroepiandrosterone and Peroxisome Proliferators: Identification of the Negative Regulatory Region of the Gene
Mol. Pharmacol., July 1, 2003; 64(1): 113 - 122.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
D. Mayer, K. Forstner, and K. Kopplow
Induction and Modulation of Hepatic Preneoplasia and Neoplasia in the Rat by Dehydroepiandrosterone
Toxicol Pathol, January 1, 2003; 31(1): 103 - 112.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
M. M. Simile, M. R. De Miglio, D. Calvisi, M. R. Muroni, M. Frau, G. Asara, L. Daino, L. Deiana, R. M. Pascale, and F. Feo
Long-term dehydroepiandrosterone and 16{{alpha}}-fluoro-5-androsten-17-one administration enhances DNA synthesis and induces expression of c-fos and c-Ha-ras in a selected population of preneoplastic lesions in liver of diethylnitrosamine-initiated rats
Carcinogenesis, February 1, 2001; 22(2): 301 - 308.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Dashtaki, A. R. Whorton, T. M. Murphy, P. Chitano, W. Reed, and T. P. Kennedy
Dehydroepiandrosterone and Analogs Inhibit DNA Binding of AP-1 and Airway Smooth Muscle Proliferation
J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 876 - 883.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.